Genetic Technologies (GENE) Fails to deliver data

Key failure to deliver metrics for Genetic Technologies:

• Last SEC data release: 2025-09-30
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: A$0 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Genetic Technologies (GENE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2023

Genetic Technologies (GENE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	N/A	A$1.51 M	🇺🇸 USA
Myriad Genetics MYGN	A$0.01 M	A$0.95 M	🇺🇸 USA
LabCorp LH	A$14.02 M	A$32.16 M	🇺🇸 USA
Quest Diagnostics DGX	A$10.73 M	A$37.61 M	🇺🇸 USA
Compugen CGEN	A$0.32 M	A$0.78 M	🇮🇱 Israel
Danaher DHR	A$70.52 M	A$0.17 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$18.61 M	A$70.68 M	🇺🇸 USA
Neogen NEOG	A$0.7 M	A$27.6 M	🇺🇸 USA